Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. share price is ₹1,443.60 as of July 26, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

The 52-week high and low of Glenmark Pharmaceuticals Ltd. is ₹1,449.00 and ₹722.25 respectively as of July 26, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

The Upper Circuit of Glenmark Pharmaceuticals Ltd. is ₹1,582. The Lower Circuit of Glenmark Pharmaceuticals Ltd. is ₹1,295.

Glenmark Pharmaceuticals Ltd. reported an ROE of -21.93% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Glenmark Pharmaceuticals Ltd., Promoter held 46.6%, the FII held 21%, DII held 14% and the public held 18.4% of the total shares.

You can easily buy shares of Glenmark Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

The fair value of Glenmark Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.